Completed NA INTERVENTIONAL 3-arm NCT01055041

Controller Medications in the Management of Bronchial Asthma

A Randomized, Open Labeled Comparative Study to Assess the Efficacy and Safety of Controller Medications as Add on to Inhaled Steroid and Long Acting β2 Agonist in Treatment of Moderate to Severe Persistent Bronchial Asthma

Sponsor: Government Medical College, Bhavnagar

Conditions Moderate to Severe Persistent Bronchial Asthma

Interventions Doubling the dose of inhaled budesonide and formeterol inhaled budesonide and formeterol plus oral doxophylline inhaled budesonide and formeterol plus oral montelukast

Updated 4 times since 2017 Last updated: Jan 22, 2010 Started: Dec 31, 2008 Primary completion: Jun 30, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Moderate to Severe Persistent Bronchial Asthma, this trial is completed. The trial is conducted by Government Medical College, Bhavnagar and has accumulated 4 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Government Medical College, Bhavnagar

Data source: Government Medical College, Bhavnagar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bhavnagar, India